AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05211570 · RECRUITING

Trial details

NCT number: NCT05211570
Sponsor: AB Science
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia, in Relapse Myelodysplastic Syndrome Acute Myeloid Leukemia

Start date: 2022-06-01
Primary completion: 2026-08-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.